Daniela Huber

Title: Innovator Daniela Huber: Pioneering Abuse-Deterrent Pharmaceutical Compositions

Introduction

Daniela Huber, located in Hollabrunn, Austria, is a proficient inventor with a remarkable contribution to the field of pharmaceuticals. With a total of two patents to her name, her work focuses on developing innovative solutions to combat drug abuse, paving the way for safer pharmaceutical compositions.

Latest Patents

Daniela's latest patents include an abuse-deterrent pharmaceutical composition that features a drug with an enzyme-reactive functional group. This composition is designed to prevent misuse by containing the drug in a stable state until it is intended for therapeutic use. Another notable patent is focused on pharmaceutical compositions comprising oxycodone and an oxycodone-processing enzyme. This design maintains the drug in a storage-stable state, hindering any potential enzymatic activity that could lead to abuse.

Career Highlights

Daniela Huber is associated with G.L. Pharma GmbH, where she applies her expertise in pharmaceutical innovation. Her dedication to developing abuse-deterrent formulations significantly enhances the responsibility of pharmaceutical practices, addressing urgent societal concerns related to drug misusage.

Collaborations

Throughout her career, Daniela has collaborated with esteemed colleagues such as Georg Guebitz and Katrin Greimel. These collaborations have enriched her research and strengthened the innovation process, underscoring the importance of teamwork in advancing pharmaceutical development.

Conclusion

With her groundbreaking work on abuse-deterrent pharmaceutical compositions, Daniela Huber stands out as an influential inventor in the pharmaceutical industry. Her contributions not only demonstrate her expertise and dedication but also reflect a broader commitment to public health and safety in drug administration. As the industry continues to evolve, her innovations will play a crucial role in shaping responsible pharmaceutical practices.